These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17822717)

  • 1. Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats.
    Choi S; DiSilvio B; Unangst J; Fernstrom JD
    Life Sci; 2007 Sep; 81(12):1024-30. PubMed ID: 17822717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
    Cooper GD; Harrold JA; Halford JC; Goudie AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
    Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
    Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance.
    Lykkegaard K; Larsen PJ; Vrang N; Bock C; Bock T; Knudsen LB
    Schizophr Res; 2008 Aug; 103(1-3):94-103. PubMed ID: 18579346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic olanzapine administration in rats: effect of route of administration on weight, food intake and body composition.
    Mann S; Chintoh A; Giacca A; Fletcher P; Nobrega J; Hahn M; Remington G
    Pharmacol Biochem Behav; 2013 Feb; 103(4):717-22. PubMed ID: 23234835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment with olanzapine via a novel infusion pump induces adiposity in male rats.
    Shobo M; Yamada H; Koakutsu A; Hamada N; Fujii M; Harada K; Ni K; Matsuoka N
    Life Sci; 2011 Apr; 88(17-18):761-5. PubMed ID: 21356217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of systolic blood pressure in an animal model of olanzapine induced weight gain.
    Patil BM; Kulkarni NM; Unger BS
    Eur J Pharmacol; 2006 Dec; 551(1-3):112-5. PubMed ID: 17046744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats.
    Fell MJ; Marshall KM; Williams J; Neill JC
    J Psychopharmacol; 2004 Jun; 18(2):149-55. PubMed ID: 15260902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.
    Minet-Ringuet J; Even PC; Goubern M; Tomé D; de Beaurepaire R
    Appetite; 2006 May; 46(3):254-62. PubMed ID: 16551485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat.
    Hartfield AW; Moore NA; Clifton PG
    Psychopharmacology (Berl); 2003 May; 167(2):115-22. PubMed ID: 12658526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever.
    Kluge M; Schuld A; Schacht A; Himmerich H; Dalal MA; Wehmeier PM; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T
    Psychoneuroendocrinology; 2009 Jan; 34(1):118-28. PubMed ID: 18835660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents.
    Melkersson KI; Hulting AL
    Psychopharmacology (Berl); 2001 Mar; 154(2):205-12. PubMed ID: 11314683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.
    Shobo M; Yamada H; Mihara T; Kondo Y; Irie M; Harada K; Ni K; Matsuoka N; Kayama Y
    Behav Brain Res; 2011 Jan; 216(2):561-8. PubMed ID: 20816897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression.
    Han M; Deng C; Burne TH; Newell KA; Huang XF
    Psychoneuroendocrinology; 2008 Jun; 33(5):569-80. PubMed ID: 18358632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of Ovarian Secretions Reverts the Anabolic Action of Olanzapine in Female Rats.
    Skrede S; González-García I; Martins L; Berge RK; Nogueiras R; Tena-Sempere M; Mellgren G; Steen VM; López M; Fernø J
    Int J Neuropsychopharmacol; 2017 Dec; 20(12):1005-1012. PubMed ID: 29020342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine-induced weight gain: chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution.
    van der Zwaal EM; Luijendijk MC; Adan RA; la Fleur SE
    Eur J Pharmacol; 2008 May; 585(1):130-6. PubMed ID: 18378227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of avoidance behaviour following repeated intermittent treatment with clozapine, olanzapine or D,L-govadine.
    Ashby DM; Lapish CC; Phillips AG
    Behav Pharmacol; 2015 Feb; 26(1-2):133-8. PubMed ID: 25325293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of thermogenesis in antipsychotic drug-induced weight gain.
    Stefanidis A; Verty AN; Allen AM; Owens NC; Cowley MA; Oldfield BJ
    Obesity (Silver Spring); 2009 Jan; 17(1):16-24. PubMed ID: 19107124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antipsychotics: comparison of weight gain liabilities.
    Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
    J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-lowering effects of tetradecylthioacetic acid in antipsychotic-exposed, female rats: challenges with long-term treatment.
    Skrede S; Fernø J; Bjørndal B; Brede WR; Bohov P; Berge RK; Steen VM
    PLoS One; 2012; 7(11):e50853. PubMed ID: 23226405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.